Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 3 | |
Outperform | 9 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 12 analysts offering 12 month price targets for Iovance Biotherapeutics Inc have a median target of 24.00, with a high estimate of 34.00 and a low estimate of 10.00. The median estimate represents a 131.88% increase from the last price of 10.35.
High | 228.5% | 34.00 |
Med | 131.9% | 24.00 |
Low | -3.4% | 10.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 30, 2024.
Average growth rate | +7.50% |
Average growth rate | -6.10% |
More ▼
Revenue history & estimates in USD
Average growth rate | +1,099.67% |
Average growth rate | 0.00% |
More ▼